"JPMorgan asserts that Colgate-Palmolive is well positioned to continue outperforming its peers thanks to its emerging markets mix. Q1 2026 backed that view, with emerging markets organic sales growth of 6% and 4% volume growth."
"Colgate-Palmolive CEO Noel Wallace declared, 'We delivered a strong start to 2026, with broad-based top and bottom-line growth.'"
"The company carries a market cap of roughly $70 billion and is a dividend king with over 60 consecutive years of dividend increases."
JPMorgan raised Colgate-Palmolive's price target to $96, maintaining an Overweight rating due to strong sales growth in emerging markets. The company reported a 6% organic sales growth in Q1 2026, with Latin America leading at 15% net sales increase. Colgate-Palmolive's adjusted EPS of $0.97 surpassed the $0.94 consensus, marking its fourth consecutive EPS beat. The stock is viewed as a core holding for income-oriented investors, trading at $85.80 with a trailing P/E of 33x and a forward P/E of 23x.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]